It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Using real-time TIRF microscopy imaging, we identify sites of clathrin and dynamin-independent CLIC/GEEC (CG) endocytic vesicle formation. This allows spatio-temporal localisation of known molecules affecting CG endocytosis; GBF1 (a GEF for ARF1), ARF1 and CDC42 which appear sequentially over 60 s, preceding scission. In an RNAi screen for BAR domain proteins affecting CG endocytosis, IRSp53 and PICK1, known interactors of CDC42 and ARF1, respectively, were selected. Removal of IRSp53, a negative curvature sensing protein, abolishes CG endocytosis. Furthermore, the identification of ARP2/3 complex at CG endocytic sites, maintained in an inactive state reveals a function for PICK1, an ARP2/3 inhibitor. The spatio-temporal sequence of the arrival and disappearance of the molecules suggest a mechanism for a clathrin and dynamin-independent endocytic process. Coincident with the loss of PICK1 by GBF1-activated ARF1, CDC42 recruitment leads to the activation of IRSp53 and the ARP2/3 complex, resulting in a burst of F-actin polymerisation potentially powering scission.
Several endocytic pathways operate simultaneously at the cell surface, including the clathrin and dynamin-independent CLIC/GEEC (CG) pathway. Here the authors show that small GTPases and BAR domain proteins regulate branched actin to make clathrin and dynamin-independent endocytic vesicles.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 National Centre for Biological Science (TIFR), Bangalore, India (GRID:grid.22401.35) (ISNI:0000 0004 0502 9283)
2 University of Queensland, Institute for Molecular Bioscience, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); University of Queensland, Centre for Microscopy and Microanalysis, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
3 IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy (GRID:grid.7678.e) (ISNI:0000 0004 1757 7797); University of Milan, Department of Oncology and Hemato-Oncology, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822)
4 National Centre for Biological Science (TIFR), Bangalore, India (GRID:grid.22401.35) (ISNI:0000 0004 0502 9283); National Centre for Biological Sciences (TIFR), Simons Centre for the Study of Living Machines, Bangalore, India (GRID:grid.22401.35) (ISNI:0000 0004 0502 9283)
5 National Centre for Biological Science (TIFR), Bangalore, India (GRID:grid.22401.35) (ISNI:0000 0004 0502 9283); Institute for Stem Cell Biology and Regenerative Medicine, Bangalore, India (GRID:grid.475408.a) (ISNI:0000 0004 4905 7710)